Nuvalent, Inc.
NUVL • NASDAQ
Nuvalent, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO James R. Porter, with a market cap of $8.4B.
Market Cap$8.4B
Employees106.0
CEOJames R. Porter
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
Nuvalent, Inc. FAQ
Common questions about Nuvalent, Inc.
Nuvalent, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026 before market open. Analysts estimate revenue of $486.0K.
Nuvalent, Inc. has approximately 106 employees.